The disclosure relates to the mannose derivatives of formula (I) where R1 is aryl other than optionally substituted phenyl, heteroaryl, heterocyclyl with 5 or more atoms, optionally substituted phenylamino, or optionally substituted phenylthioureido and their use in the manufacture of medicaments for treatment of bacterial infections particularly by virulent strains of E. coli.